NWSA vs TCRT · rev $9.03B vs $5.6M cap
NWSA (NWSA) versus Alaunos Therapeutics Inc (TCRT) — a side-by-side from cached financials, not a winner call.
NWSA (NWSA) common stock.
Alaunos Therapeutics Inc (TCRT) is a biotechnology company listed on NASDAQ.
Latest reported NWSA revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 328.1% from 2025-06-30 to 2026-06-30. NWSA currently screens at market cap $0.
Latest reported TCRT revenue for 2026-06-30 was $0. Net income was -$2.0M. TCRT currently screens at market cap $5.6M.
NWSA currently screens at market cap $0. TCRT currently screens at market cap $5.6M.
Not investment advice. Open the NWSA and TCRT stock pages for the full models.
Not investment advice.